Aadi Bioscience Stock Short Ratio
| AADI Stock | USD 2.22 0.08 3.48% |
Aadi Bioscience fundamentals help investors to digest information that contributes to Aadi Bioscience's financial success or failures. It also enables traders to predict the movement of Aadi Stock. The fundamental analysis module provides a way to measure Aadi Bioscience's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Aadi Bioscience stock.
Aadi | Short Ratio |
Aadi Bioscience Company Short Ratio Analysis
Aadi Bioscience's Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
Current Aadi Bioscience Short Ratio | 3.24 X |
Most of Aadi Bioscience's fundamental indicators, such as Short Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Aadi Bioscience is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Aadi Short Ratio Driver Correlations
Understanding the fundamental principles of building solid financial models for Aadi Bioscience is extremely important. It helps to project a fair market value of Aadi Stock properly, considering its historical fundamentals such as Short Ratio. Since Aadi Bioscience's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Aadi Bioscience's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Aadi Bioscience's interrelated accounts and indicators.
Click cells to compare fundamentals
The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.
| Competition |
Aadi Price To Sales Ratio
Price To Sales Ratio |
|
Based on the latest financial disclosure, Aadi Bioscience has a Short Ratio of 3.24 times. This is 16.92% lower than that of the Biotechnology sector and 56.28% lower than that of the Health Care industry. The short ratio for all United States stocks is 19.0% higher than that of the company.
Aadi Short Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Aadi Bioscience's direct or indirect competition against its Short Ratio to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Aadi Bioscience could also be used in its relative valuation, which is a method of valuing Aadi Bioscience by comparing valuation metrics of similar companies.Aadi Bioscience is currently under evaluation in short ratio category among its peers.
Aadi Bioscience ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Aadi Bioscience's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Aadi Bioscience's managers, analysts, and investors.Environmental | Governance | Social |
Aadi Bioscience Institutional Holders
Institutional Holdings refers to the ownership stake in Aadi Bioscience that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Aadi Bioscience's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Aadi Bioscience's value.| Shares | Goldman Sachs Group Inc | 2024-06-30 | 154.3 K | Jane Street Group Llc | 2024-06-30 | 134.2 K | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 129.8 K | Susquehanna International Group, Llp | 2024-06-30 | 99.9 K | Bridgeway Capital Management, Llc | 2024-09-30 | 93.3 K | Verition Fund Managegment, Llc | 2024-06-30 | 82.4 K | Ubs Group Ag | 2024-06-30 | 70.4 K | State Street Corp | 2024-06-30 | 68.7 K | Northern Trust Corp | 2024-09-30 | 68.5 K | Venbio Select Advisor Llc | 2024-09-30 | 2.8 M | Bml Capital Management Llc | 2024-09-30 | 2 M |
Aadi Fundamentals
| Return On Equity | -0.66 | ||||
| Return On Asset | -0.35 | ||||
| Profit Margin | (2.46) % | ||||
| Operating Margin | (1.49) % | ||||
| Current Valuation | (4.98 M) | ||||
| Shares Outstanding | 24.65 M | ||||
| Shares Owned By Insiders | 9.96 % | ||||
| Shares Owned By Institutions | 49.06 % | ||||
| Number Of Shares Shorted | 281.12 K | ||||
| Price To Book | 0.82 X | ||||
| Price To Sales | 2.26 X | ||||
| Revenue | 24.35 M | ||||
| Gross Profit | (18.78 M) | ||||
| EBITDA | (65.36 M) | ||||
| Net Income | (65.77 M) | ||||
| Cash And Equivalents | 118.74 M | ||||
| Cash Per Share | 5.65 X | ||||
| Total Debt | 1.27 M | ||||
| Debt To Equity | 0.02 % | ||||
| Current Ratio | 9.87 X | ||||
| Book Value Per Share | 2.80 X | ||||
| Cash Flow From Operations | (59.66 M) | ||||
| Short Ratio | 3.24 X | ||||
| Earnings Per Share | (2.28) X | ||||
| Target Price | 1.88 | ||||
| Number Of Employees | 53 | ||||
| Beta | 0.37 | ||||
| Market Capitalization | 56.69 M | ||||
| Total Asset | 132.42 M | ||||
| Retained Earnings | (268.96 M) | ||||
| Working Capital | 98.19 M | ||||
| Net Asset | 132.42 M |
About Aadi Bioscience Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Aadi Bioscience's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aadi Bioscience using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aadi Bioscience based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether Aadi Bioscience offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Aadi Bioscience's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Aadi Bioscience Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Aadi Bioscience Stock:Check out Aadi Bioscience Piotroski F Score and Aadi Bioscience Altman Z Score analysis. For more detail on how to invest in Aadi Stock please use our How to Invest in Aadi Bioscience guide.You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aadi Bioscience. If investors know Aadi will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aadi Bioscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.28) | Revenue Per Share 0.929 | Quarterly Revenue Growth 0.21 | Return On Assets (0.35) | Return On Equity (0.66) |
The market value of Aadi Bioscience is measured differently than its book value, which is the value of Aadi that is recorded on the company's balance sheet. Investors also form their own opinion of Aadi Bioscience's value that differs from its market value or its book value, called intrinsic value, which is Aadi Bioscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aadi Bioscience's market value can be influenced by many factors that don't directly affect Aadi Bioscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aadi Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aadi Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aadi Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.